insights_auto
Why is BBIO down 3,73%?
Dive Deeperchevron_right
BBIO:NASDAQ
BridgeBio Pharma Inc
63,30 $
arrow_downward
-3,73%(-2,45) 1D
63,04 $
arrow_downward
-0,41% (-0,26)bedtimeAfter hours
Closed: 13 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BBIO...
Open
66,05 $
High
66,05 $
Low
62,94 $
Mkt. cap
12,37 млрд
Avg. vol.
2,72 млн
Volume
2,71 млн
52-wk high
93,42 $
52-wk low
52,75 $
EPS
-3,57 $
Beta
0,97
Shares outstanding
195,49 млн
No. of employees
1 мың
Open
66,05 $
High
66,05 $
Low
62,94 $
Mkt. cap
12,37 млрд
Avg. vol.
2,72 млн
Volume
2,71 млн
52-wk high
93,42 $
52-wk low
52,75 $
EPS
-3,57 $
Beta
0,97
Shares outstanding
195,49 млн
No. of employees
1 мың
News stories
From web sources and news partners
Grit Daily News
·
3 сағат бұрын
Why BridgeBio’s $1 Billion Investment Signals More Than Market Confidence
Seeking Alpha
·
13 сағат бұрын
BridgeBio: Maintaining 'Strong Buy' Additional Encaleret Data ADH1 And Three Expected FDA Reviews
TipRanks
·
15 сағат бұрын
BridgeBio Wins FDA Priority Review for Infigratinib
Simply Wall Street
·
21 сағат бұрын
BridgeBio Pharma (BBIO) Gains Clinical Momentum, Is The Upside Already Priced In?
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1 мың
Founded2015
HeadquartersПало Альто, Калифорния, Америка Құрама Штаттары
Sector-
Websitebridgebio.com